Hepatorenal syndrome in cirrhosis: Pathogenesis and treatment
- 1 May 2002
- journal article
- review article
- Published by Elsevier in Gastroenterology
- Vol. 122 (6) , 1658-1676
- https://doi.org/10.1053/gast.2002.33575
Abstract
No abstract availableKeywords
This publication has 172 references indexed in Scilit:
- Noradrenalin for treatment of type I hepatorenal syndrome (HRS)Journal of Hepatology, 2001
- Effects of spontaneous bacterial peritonitis (SBP) on systemic and splanchnic hemodynamics in patients with cirrhosisJournal of Hepatology, 2001
- Ascites and hepatorenal syndrome during cirrhosis: two entities or the continuation of the same complication?Journal of Hepatology, 1999
- Oral misoprostol or intravenous prostaglandin E2 do not improve renal function in patients with cirrhosis and ascites with hyponatremia or renal failureJournal of Hepatology, 1993
- Hemodynamic and humoral changes after liver transplantation in patients with cirrhosisHepatology, 1993
- Pathogenesis of arterial hypotension in cirrhotic rats with ascites: Role of endogenous nitric oxideHepatology, 1992
- Systemic, splanchnic and renal hemodynamic effects of a dopaminergic dose of dopamine in patients with cirrhosisHepatology, 1991
- Sympathetic nervous activity, renin‐angiotensin system and renal excretion of prostaglandin E2 in cirrhosis. Relationship to functional renal failure and sodium and water excretionEuropean Journal of Clinical Investigation, 1983
- Potential Role of Increased Sympathetic Activity in Impaired Sodium and Water Excretion in CirrhosisNew England Journal of Medicine, 1982
- Prognostic value of spontaneous hyponatremia in cirrhosis with ascitesDigestive Diseases and Sciences, 1976